Will Zimulti’s Outlook Be Affected By Suicidality Signal?
FDA’s Endocrinologic and Metabolic Drugs Advisory Committee will address psychiatric and neurological profiles of Sanofi-Aventis’ rimonabant for weight management.
FDA’s Endocrinologic and Metabolic Drugs Advisory Committee will address psychiatric and neurological profiles of Sanofi-Aventis’ rimonabant for weight management.